{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T21:36:07Z","timestamp":1780349767979,"version":"3.54.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,1,14]],"date-time":"2023-01-14T00:00:00Z","timestamp":1673654400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,14]],"date-time":"2023-01-14T00:00:00Z","timestamp":1673654400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1007\/s12185-023-03532-y","type":"journal-article","created":{"date-parts":[[2023,1,14]],"date-time":"2023-01-14T18:02:33Z","timestamp":1673719353000},"page":"919-924","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Successful azacitidine therapy for myelodysplastic syndrome associated with VEXAS syndrome"],"prefix":"10.1007","volume":"117","author":[{"given":"Asami","family":"Kataoka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chisaki","family":"Mizumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6704-3633","authenticated-orcid":false,"given":"Junya","family":"Kanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Iwasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maki","family":"Sakurada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomomi","family":"Oka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masakazu","family":"Fujimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosuke","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohei","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhito","family":"Nannya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seishi","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akifumi","family":"Takaori-Kondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,14]]},"reference":[{"issue":"27","key":"3532_CR1","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.1056\/NEJMoa2026834","volume":"383","author":"DB Beck","year":"2020","unstructured":"Beck DB, Ferrada MA, Sikora KA, Ombrello AK, Collins JC, Pei W, Balanda N, et al. Somatic mutations in UBA1 and severe adult-onset autoinflammatory disease. N Engl J Med. 2020;383(27):2628\u201338.","journal-title":"N Engl J Med"},{"issue":"1","key":"3532_CR2","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s40164-021-00217-2","volume":"10","author":"H Huang","year":"2021","unstructured":"Huang H, Zhang W, Cai W, Liu J, Wang H, Qin T, et al. VEXAS syndrome in myelodysplastic syndrome with autoimmune disorder. Exp Hematol Oncol. 2021;10(1):23.","journal-title":"Exp Hematol Oncol"},{"issue":"Supplement1","key":"3532_CR3","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1182\/blood-2020-140480","volume":"136","author":"IE Obiorah","year":"2020","unstructured":"Obiorah IE, Beck DB, Wang W, Ombrello A, Ferrada MA, Zhijie Wu, et al. Myelodysplasia and bone marrow manifestations of somatic\u00a0UBA1\u00a0mutated autoinflammatory disease. Blood. 2020;136(Supplement1):20\u20131.","journal-title":"Blood"},{"issue":"26","key":"3532_CR4","first-page":"3591","volume":"137","author":"PC Grayson","year":"2021","unstructured":"Grayson PC, Patel BA, Young NS. VEXAS syndrome. Blood. 2021;137(26):3591\u20134.","journal-title":"Blood"},{"key":"3532_CR5","doi-asserted-by":"crossref","unstructured":"Ars\u00e8ne M\u00e9kinian, Lin-Pierre Zhao, Kristell Desseaux, Rose Rose, Laurent Pascal, Pierre Peterlin, et al.; A Phase II Study of the Efficacy and Tolerance of Azacitidine (AZA) in Steroid Dependent\/Refractory Systemic Autoimmune and Inflammatory Disorders (SAID) Associated with MDS or CMML (GFM- AZA-SAID -trial).\u00a0Blood\u00a02021;138 (Supplement 1): 3697.","DOI":"10.1182\/blood-2021-150904"},{"issue":"5","key":"3532_CR6","doi-asserted-by":"publisher","first-page":"e117","DOI":"10.1093\/rheumatology\/keab866","volume":"61","author":"I Cordts","year":"2022","unstructured":"Cordts I, Hecker JS, Gauck D, Park J, H\u00e4rtl J, G\u00fcnthner R, et al. Successful treatment with azacitidine in VEXAS syndrome with prominent myofasciitis. Rheumatol (Oxf). 2022;61(5):e117\u20139.","journal-title":"Rheumatol (Oxf)"},{"issue":"12","key":"3532_CR7","doi-asserted-by":"publisher","DOI":"10.1097\/HS9.0000000000000661","volume":"5","author":"MHGP Raaijmakers","year":"2021","unstructured":"Raaijmakers MHGP, Hermans M, Aalbers A, Rijken M, Dalm VASH, van Daele P, et al. Azacitidine Treatment for VEXAS Syndrome. Hemasphere. 2021;5(12): e661.","journal-title":"Hemasphere"},{"issue":"1\u20132","key":"3532_CR8","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s44228-022-00002-w","volume":"4","author":"M Manzoni","year":"2022","unstructured":"Manzoni M, Bosi A, Fabris S, Lionetti M, Salerio S, Migliorini AC, et al. Clinical, morphological and clonal progression of VEXAS syndrome in the context of myelodysplasia treated with azacitidine. Clin Hematol Int. 2022;4(1\u20132):52\u20135.","journal-title":"Clin Hematol Int"},{"issue":"26","key":"3532_CR9","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1056\/NEJMoa1409405","volume":"371","author":"G Genovese","year":"2014","unstructured":"Genovese G, K\u00e4hler AK, Handsaker RE, Lindberg J, Rose SA, Bakhoum SF, et al. Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence. N Engl J Med. 2014;371(26):2477\u201387.","journal-title":"N Engl J Med"},{"issue":"26","key":"3532_CR10","doi-asserted-by":"publisher","first-page":"2488","DOI":"10.1056\/NEJMoa1408617","volume":"371","author":"S Jaiswal","year":"2014","unstructured":"Jaiswal S, Fontanillas P, Flannick J, Manning A, Grauman PV, Mar BG, et al. Age-related clonal hematopoiesis associated with adverse outcomes. N Engl J Med. 2014;371(26):2488\u201398.","journal-title":"N Engl J Med"},{"issue":"2","key":"3532_CR11","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1161\/CIRCRESAHA.120.317104","volume":"128","author":"WT Abplanalp","year":"2021","unstructured":"Abplanalp WT, Cremer S, John D, Hoffmann J, Schuhmacher B, Merten M, et al. Clonal hematopoiesis-driver dnmt3a mutations alter immune cells in heart failure. Circ Res. 2021;128(2):216\u201328.","journal-title":"Circ Res"},{"issue":"7","key":"3532_CR12","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20202733","volume":"218","author":"JY Lim","year":"2021","unstructured":"Lim JY, Duttke SH, Baker TS, Lee J, Gambino KJ, Venturini NJ, et al. DNMT3A haploinsufficiency causes dichotomous DNA methylation defects at enhancers in mature human immune cells. J Exp Med. 2021;218(7): e20202733.","journal-title":"J Exp Med"},{"issue":"8","key":"3532_CR13","doi-asserted-by":"publisher","first-page":"E1490","DOI":"10.1073\/pnas.1616420114","volume":"114","author":"C Leoni","year":"2017","unstructured":"Leoni C, Montagner S, Rinaldi A, Bertoni F, Polletti S, Balestrieri C, et al. Dnmt3a restrains mast cell inflammatory responses. Proc Natl Acad Sci USA. 2017;114(8):E1490\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"3532_CR14","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1111\/bjd.20805","volume":"186","author":"S Georgin-Lavialle","year":"2022","unstructured":"Georgin-Lavialle S, Terrier B, Guedon AF, Heiblig M, Comont T, Lazaro E, et al. Further characterization of clinical and laboratory features in VEXAS syndrome: large-scale analysis of a multicentre case series of 116 French patients. Br J Dermatol. 2022;186(3):564\u201374.","journal-title":"Br J Dermatol"},{"issue":"1","key":"3532_CR15","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1080\/16078454.2019.1657613","volume":"24","author":"S Liang","year":"2019","unstructured":"Liang S, Zhou X, Pan H, Yang Y, Shi L, Wang L. Prognostic value of DNMT3A mutations in myelodysplastic syndromes: a meta-analysis. Hematology. 2019;24(1):613\u201322.","journal-title":"Hematology"},{"key":"3532_CR16","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26786","author":"AA Mangaonkar","year":"2022","unstructured":"Mangaonkar AA, Langer KJ, Lasho TL, Finke C, Litzow MR, Hogan WJ, et al. Reduced intensity conditioning allogeneic hematopoietic stem cell transplantation in VEXAS syndrome: Data from a prospective series of patients. Am J Hematol. 2022. https:\/\/doi.org\/10.1002\/ajh.26786.","journal-title":"Am J Hematol"},{"issue":"22","key":"3532_CR17","first-page":"00181","volume":"S0190\u20139622","author":"D Sterling","year":"2022","unstructured":"Sterling D, Duncan ME, Philippidou M, Salisbury JR, Kulasekararaj AG, Basu TN. VEXAS syndrome (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) for the dermatologist. J Am Acad Dermatol. 2022;S0190\u20139622(22):00181\u20135.","journal-title":"J Am Acad Dermatol"},{"issue":"11","key":"3532_CR18","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1001\/jamadermatol.2021.3344","volume":"157","author":"E Zakine","year":"2021","unstructured":"Zakine E, Schell B, Battistella M, Vignon-Pennamen MD, Chasset F, Mah\u00e9vas T, et al. UBA1 variations in neutrophilic dermatosis skin lesions of patients With VEXAS syndrome. JAMA Dermatol. 2021;157(11):1349\u201354.","journal-title":"JAMA Dermatol"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-023-03532-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12185-023-03532-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-023-03532-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,28]],"date-time":"2023-05-28T12:03:08Z","timestamp":1685275388000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12185-023-03532-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,14]]},"references-count":18,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["3532"],"URL":"https:\/\/doi.org\/10.1007\/s12185-023-03532-y","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,14]]},"assertion":[{"value":"17 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 December 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing financial interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}